VIRX

Vir

This clinical-stage biopharmaceutical company develops medicines for serious infectious diseases and cancer for global patients.

T-CURX

This biotech company develops non-viral CAR-T cell therapies to treat patients with leukaemia, lymphoma and solid tumours.

CARGO Therapeutics

This biotechnology company develops engineered cell therapies to treat cancer patients with relapsed or resistant lymphoma.

iOnctura

The company develops precision small-molecule medicines to treat patients with neglected and hard-to-treat solid tumours and cancers.

VTYX

This biopharmaceutical company develops oral small-molecule medicines for patients with autoimmune, inflammatory, cardiovascular and neurodegenerative diseases.

Inhibrx

Inhibrx Biosciences develops biologic therapeutic candidates for patients with various cancers and rare diseases using its proprietary single-domain antibody platform.

NKIO

This company develops natural killer cell therapies and small molecule medicines to treat solid tumours for patients with cancer and inflammatory diseases.

ADXS

The company develops bioengineered immunotherapies and precision small molecule drugs for patients with rare tumors and aggressive cancers.